China and India. Then generally excited about leveraging U.S. alliance dynamics and building global policy advocacy networks, especially for risks from technologies that seem to be becoming cheaper and more accessible, e.g. in synthetic biology
China and India. Then generally excited about leveraging U.S. alliance dynamics and building global policy advocacy networks, especially for risks from technologies that seem to be becoming cheaper and more accessible, e.g. in synthetic biology